Innovation of diagnostics and treatment of selective mutism: towards personalized care

Completed

• Conditions: not daring to speak; selective mutism; 10002861

• Registration Number: NL-OMON49550
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 320

Inclusion Criteria

Eligible for participation in the study of the treatment effectivity are:
patients under 18 years, with selective mutism as a primary diagnosis and
estimated intelligence above 85 in the patient and parents., Eligible for
participation in the healthy control group for the validation study are
children between the age of 3 and 18.

Exclusion Criteria

Study of treatment effectivity: Mental retardation in patient and/or parents,
inability to read or write Dutch, other primary diagnosis, having had cognitive
behavioral therapy for selective mutism in the past year., Validation Study:
diagnosis of selective mutism

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>(Please also see METC protocol)<br /><br><br /><br>The primary outcome of the study is the symptoms of selective mutism in the<br /><br>child. This is being measured by the use of the SMQ questionnaire and the<br /><br>selective mutism chapter of the ADIS-C clinical interview.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>(Please also see METC protocol)<br /><br><br /><br>Secundary outcomes:<br /><br>- Anxiety and mood problems<br /><br>- Other psychopathology in the child<br /><br>- Self image<br /><br>- Quality of life<br /><br>- Consumption of care</p><br>